GLN galan lithium limited

7.14%

10.5¢

General Discussion Banter GLN, page-17559

First 17559 Last

Share
Profile

Follow
AyDee

2,350 Posts.

277

15/04/25

11:16

Post #: 78694203
Share

Originally posted by mondyinvest: ↑

It’s a huge red flag. Chemphys have either been booted or bailed (likely they won’t hold their $4.5M stake).

Galan have now completely departed from their studied approach which took so many years and are trying to press ahead with a completely different approach to what they have promoted for so long.

I didn’t want to say anything before now but the only reason no deal details leaked is because they tried to get at least $25M and there was no demand so they’ve had to scale back to $10M. It took them this long to get a term sheet out because the Petra phone calls didn’t produce the required demand.

Now after all these years and all this dilution they’re not even going to own the processing plant and so the project will be completely at the mercy of a third party (brine ponds are useless without the processing ability).

It is a sad but not unexpected end to what could have been a great project. This for me has become *the* textbook example of how inexperience and arrogance can completely ruin a good resource. It’s no wonder people pay overs for highly esteemed management teams ie Capricorn, Genesis, etc.

Good luck if you hold on from here but I have *never* seen a project succeed when it departs from its baseline studies and tries to fudge its way into construction.

Expand

Fair points there Mondy.
I'm very curious to see if any other info comes with this in the morning.

Is Chemphys then buying the processed product after Authium have treated it?

GLN Price at posting: 12.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 17559 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.5¢		Change 0.007(7.14%)		Mkt cap ! $100.5M

Open	High	Low	Value	Volume
9.9¢	11.0¢	9.9¢	$324.7K	3.146M

Buyers (Bids)

No.	Vol.	Price($)
2	14450	10.5¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	1334688	22

View Market Depth

No.	Vol.	Price($)
2	14450	0.105
9	954000	0.100
6	88026	0.099
5	268267	0.098
1	25000	0.097

Price($)	Vol.	No.
0.110	1334688	22
0.115	1222853	16
0.120	1177837	7
0.125	317018	5
0.130	403000	5

Last trade - 16.10pm 27/06/2025 (20 minute delay)

GLN (ASX) Chart

General Discussion Banter GLN, page-17559

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

General Discussion Banter GLN, page-17559

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News